Addex Therapeutics Ltd (ADXN) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.00 to the broader market. Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Led by Timothy Mark Dyer, public since 2020-02-12.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for ADXN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.